We predict the capacity of near-infrared f luorescent signals to propagate through human tissue for noninvasive medical imaging. This analysis employs experimental measurements of a biologically relevant local f luorochrome embedded in tissuelike media and predicts the equivalent photon counts expected from breast, lung, brain, and muscle as a function of diameter by use of an analytical solution of the diffusion equation that can take into account large arbitrary geometries. The findings address feasibility issues for clinical studies and are relevant to recent development of near-infrared f luorescent probes and molecular beacons for in vivo applications.
The recent interest in novel Indocyanine derivatives, targeted dyes, and molecular beacons for in vivo imaging 1 opens exciting pathways for new modalities of disease detection based on functional and molecular contrast. The clinical utility of such probes, however, depends on imaging of f luorochromes localized deep in tissues. Currently, there exists only limited information on the detection capacity of f luorochromes distributed in the human body. In this Letter we predict the f luorescence strength expected from a small f luorescent lesion, such as a tumor, embedded in human tissue. To achieve realistic calculations, we employed a recently developed tomographic system 2 to measure experimentally the f luorescence detected from a known f luorochrome implanted in a diffuse medium. These experimental measurements were subsequently used to calibrate an analytical solution of the diffusion equation for cylindrical geometries. Using the calibrated solution, we computed the f luorescence signals expected from human breast, lung, and brain tissue as a function of diameter.
To obtain straightforward insight into f luorescence-detection capacity in tissues, we opted for a prediction model that yields a linear relationship among f luorescence counts, tumor characteristics, and instrument gain. We chose an analytical solution of the diffusion equation that is accurate when one is simulating small objects (smaller than 5-mm diameter), which is based on the Born approximation 3 :
where U fl ͑r s , r d ͒ is the f luorescence signal detected at position r d that is due to a source at position r s and a f luorochrome distribution of concentration ͓F ͑r͔͒ and volume V at position r. S 0 is a gain factor that contains the laser strength and overall system gain, g is the f luorochrome quantum yield, e is the f luorochrome extinction coefficient, and G͑r, r s , r d ͒ is the Green function solution of the diffusion equation, which combines intrinsic and f luorescence signal propagation 4 and is calculated for cylindrical geometry by use of the Kirchhoff approximation adapted for diffusive waves. 5 The Kirchhoff approximation is a very time-efficient computation method and has been used extensively in acoustics and physical optics (see Ref. 9 and references therein). All the simulations were done for a diffusive cylinder of refractive index 1.33 surrounded by air. The error introduced as a result of the Kirchhoff approximation with respect to the exact solution was, for all cases shown here, ,1%.
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Equation (1) is very useful for this analysis, since it efficiently separates the problem that is being investigated into an optical-property-dependent nonlinear component (Green function) and linearly related experimental factors, such as the laser power or detection gain (via the term S 0 ), and the tumor characteristics, such as volume or f luorochrome concentration. This separation means that, for a given medium, calculations of the f luorescence counts that are expected when the laser power is improved or the tumor volume is increased, for example, can be obtained by linear scaling of an existing simulation.
A generic geometry was employed for the simulations performed. Figure 1 depicts the middle slice of a three-dimensional setup consisting of a 12-cm-long cylinder with variable diameter and a smaller cylinder simulating a tumor, immersed in the middle of the larger cylinder at 0.5 cm off center. The small cylinder attains an equivalent volume of ϳ100 mL (4-mm diameter, 8-mm length), which represents a typical small cancer detected by current radiological techniques. The geometry was purposely asymmetric because symmetric artifacts or errors that are due to symmetric structures, if they are present, are not easily separated from real signals. We chose to simulate four basic human tissues, i.e., breast (of a young and an old adult), lung, brain, and muscle. The optical properties chosen for these tissues were generic for the near-infrared region and are summarized in Table 1 . We further assumed a typical uptake of macromolecules into malignant tumors, as previously determined by biodistribution studies, 10 which yields concentrations of ϳ100 nM of agent (i.e., 10 pmol of dye in the 100-mL tumor that was selected) 24 h after administration.
Fluorescence measurements were obtained experimentally and were subsequently used to calibrate Eq. (1). The experimental setup was identical to the geometry and dimensions shown in Fig. 1 , with the large-cylinder diameter set to 2.5 cm. The small cylinder was made from fused quartz (Wilmad Glass, Buena, N.J.) and contained 100 nM of the infrared f luorochrome Cy5.5 (Amersham Pharmacia Biotech, Piscataway, N.J.) in 0.5% Intralipid. The Cy5.5 dye has quantum yield g 0.28, extinction coefficient e 250, 000 M 21 cm 21 , absorption peaks at 675 nm, and f luorescence emission peaks at 694 nm. The large cylinder was constructed from black Delrin and contained a water solution of 0.5% Intralipid. An array of 12 140-mm͞100-mm-diameter clad͞core source fibers (Fiber Instrument Sales, Oriskany, N.Y.) was placed equidistantly around the periphery of the cylinder at the middle plane and excited the f luorochrome from multiple angles. A similar ring of 12 detection fiber bundles (Dolan-Jenner Industries, Lawrence, Mass.), each 3 mm in diameter, was placed 0.5 cm above the source ring, which was rotated by an angle of 15
± . Both the source and the detector f iber optics came face to face with the inner wall of the cylinder. The light source was a 670-nm laser diode (B&W TEK, Newark, Del.) set to 20 mW of output power at the f iber tip. Sequential light coupling into the different source fibers was accomplished with an optical switch (DiCon FiberOptics, Richmond, Calif.). For light detection, the f iber bundles were arranged on a 6 cm 3 6 cm f lat black surface (the f ibers were placed 1 cm apart) and imaged on a 1.2 cm 3 1.2 cm, 240 ± Ccooled CCD chip by a VersArray 512B CCD camera (Roper Scientific, Acton, Mass.) and a Micro-Nikkor f ͞2.8D lens (Nikon Tokyo JP). A reference fiber was used to correct for laser light amplitude variations throughout the measurement.
Fitting the experimental measurements to Eq. (1) yielded the gain factor, S 0 , of the setup employed. By use of this experimentally determined S 0 , Eq. (1) becomes a realistic prediction model that relates f luorescence photon counts to tissue optical properties, dimensions, volume, concentration, and quantum yield. Figure 2 (a) depicts the average f luorescence strength, S, on a logarithmic scale, that is expected at the peripheries of the different tissues simulated as a function of organ diameter. S is measured in counts per second per square millimeter of CCD area, and it is calculated as the average signal measured with the f luorochrome present minus the signal measured without the f luorochrome (the background measurement that is due to CCD offset and noise and bleed-through signals allowed by the cutoff f ilter). S is a measure of the physical quantity of interest in this study, i.e., the f luorescence strength, and allows a direct observation of bulk f luorescent signals at the boundary. Figure 2 (a) indicates that the attenuation rate of breast tissue and the adult lung in the near infrared is approximately 1 order of magnitude every 4 cm, the attenuation rate in denser breast approaches 1 order of magnitude every 3 cm, muscle yields 1 order of magnitude attenuation every 2 cm, and brain tissue attenuates near-infrared light by 1 order of magnitude every 1.5 cm. In absolute terms, Fig. 2(a) denotes that f luorescent photons from small cancerlike volumes can be detected in most tissues examined, even after the photons propagate for several centimeters. This estimate is conservative, since technological advances could lead to significant detection improvements relative to the experimental setup used in this study. More-efficient photon detection can be achieved by direct fiber coupling on the CCD chip or a 1:1 lens system, yielding more than a 40-fold detection improvement. The use of higher light power could signif icantly increase the expected f luorescence photon strength, especially since we have found that no saturation or photobleaching effects occur for laser powers up to 100 mW and f luorochrome concentrations that exceed 800 nM (results not shown). For imaging purposes, increasing the exposure time and using cooled CCD chips and lower read-noise circuitry than used in this study can further improve the detection capacity. Figure 2 (b) illustrates the photon counts expected for a moderate, 2-orders-of-magnitude increase in detection capacity. There are also three horizontal lines plotted, marking the 10-, 20-, and 30-dB signal-to-noise levels achieved, assuming shot-noise-limited detection. In reality, background f luorescence (which is due primarily to nonspecific dye distribution) limits the signal-to-noise ratio achieved, since background signals can be seen as biologically induced noise after appropriate subtraction schemes. 11 Data set optimization 12 and appropriate algorithms 13 can be used to image at a low signal-to-noise ratio, and such considerations should be addressed on a case-to-case basis; this study, however, demonstrates that f luorescence imaging of human tissues becomes an issue of uptake-to-background contrast rather than of propagation feasibility. It is important to the latter argument that f luorescence offers mechanisms for multifold background suppression by use of quenching and activation (dequenching) of f luorescent probes or f luorescence resonance energy transfer. These technologies may significantly minimize background signals in vivo and, combined with advances in drug delivery and hardware improvements, surpass the predictions of this study.
